EZETIMIB TEVA CR - interactions (all)


 
The serum concentration of Ibrutinib can be increased when it is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Bezafibrate is combined with Ezetimibe.
The serum concentration of Tolvaptan can be increased when it is combined with Ezetimibe.
The serum concentration of Cerivastatin can be increased when it is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Ergotamine is combined with Ezetimibe.
The serum concentration of Ezetimibe can be increased when it is combined with Vemurafenib.
The risk or severity of adverse effects can be increased when Methysergide is combined with Ezetimibe.
The serum concentration of Lovastatin can be increased when it is combined with Ezetimibe.
The serum concentration of Ezetimibe can be increased when it is combined with Ranolazine.
The serum concentration of Pitavastatin can be increased when it is combined with Ezetimibe.
The serum concentration of Simvastatin can be increased when it is combined with Ezetimibe.
The serum concentration of Ezetimibe can be increased when it is combined with Eltrombopag.
The serum concentration of Bosutinib can be increased when it is combined with Ezetimibe.
The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Ergonovine is combined with Ezetimibe.
The serum concentration of Ezetimibe can be decreased when it is combined with Lumacaftor.
Colesevelam can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.
The serum concentration of Pravastatin can be increased when it is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Pergolide is combined with Ezetimibe.
The serum concentration of Rilpivirine can be increased when it is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin.
The risk or severity of adverse effects can be increased when Metergoline is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Lisuride is combined with Ezetimibe.
The serum concentration of Ezetimibe can be increased when it is combined with Teriflunomide.
The risk or severity of adverse effects can be increased when Nicergoline is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Fenofibrate is combined with Ezetimibe.
The serum concentration of Rosuvastatin can be increased when it is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ezetimibe.
Colestipol can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.
The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Cabergoline is combined with Ezetimibe.
The serum concentration of Ubidecarenone can be increased when it is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Ezetimibe.
The serum concentration of Mevastatin can be increased when it is combined with Ezetimibe.
The serum concentration of Fluvastatin can be increased when it is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Lysergic Acid Diethylamide is combined with Ezetimibe.
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ezetimibe.
The serum concentration of Ezetimibe can be increased when it is combined with Rolapitant.
Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.



More info